You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-MMP1 antibody - Hemopexin domain (ab38929)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab38929? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab38929 has been referenced in 6 publications.

  1. Keld R et al. The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma. Mol Cancer 9:313 (2010). WB; Human. PubMed: 21143918
  2. Barbaresi S et al. Effects of human papillomavirus type 16 E5 deletion mutants on epithelial morphology: functional characterization of each transmembrane domain. J Gen Virol 91:521-30 (2010). IHC-P; Human. PubMed: 19812262
  3. Doehn U et al. RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. Mol Cell 35:511-22 (2009). WB; Human, Dog. PubMed: 19716794
  4. Stojic J et al. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas. Neurosci Res 60:40-9 (2008). PubMed: 17980449
  5. Yuan ZQ et al. Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts. J Virol 82:6481-91 (2008). ICC/IF; Horse. PubMed: 18434409
  6. Ishikawa A et al. Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia. Neurosci Res 59:406-12 (2007). IHC-P; Human. PubMed: 17889387

Publishing research using ab38929? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"